Pharmadrug Inc C.PHRX

Alternate Symbol(s): LMLLF

PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural medicines. Sairiyo is engaged in the development of its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious diseases and rare cancers. Sairiyo is also conducting research and development (R&D) in the psychedelics space for the treatment of non-neuropsychiatric conditions. The Company also operates through SecureDose Synthetics Inc., which is a pharmaceutical research and development company focused on the development of synthetic formulations of existing drugs for potential commercialization and distribution.

CSE:PHRX - Post by User

Pharmadrug Inc > USD $70 Million needed for Stage III FDA approval for orphan

<< Previous

Bullboard Posts

Next >>

Comment by Goldy63on Mar 24, 2021 7:51pm

42 Views

Post# 32872392

RE:USD $70 Million needed for Stage III FDA approval for orphan

Jeff . FDA Approuval and big pharma comes in with plenty of money . CEO Email I posted already shut down your garbage (Page 137 and up if people want to check out Jeff ) Second your company from 4$ and change to $1.50 today ??. You should devout your time to your shareholders and share holder value Jeff . Sure looks like you have a beef with CEO Cohen . Long Buzz .

<< Previous

Bullboard Posts

Next >>

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide